Pharming reported positive Phase II results for leniolisib in rare primary immunodeficiencies linked to PI3Kδ signaling.
Filana Therapeutics shares rose after the FDA lifted a clinical hold on simufilam, allowing an epilepsy study to proceed.
Amgen said its experimental drug dazodalibep met the main goal in a late-stage Sjogren’s disease trial at 48 weeks.
Compass Therapeutics shares fell after the FDA recommended a new trial before a marketing application for tovecimig.
Nutanix acquired Ryax Technologies to expand AI compute orchestration capabilities and integrate GPU optimization into its platforms.
Brent and WTI crude prices declined as Iran signaled possible Strait of Hormuz reopening and Saudi Arabia prepared to resume exports.
Endeavour Silver paused its primary ball mill at Guanacevi Mine after a mechanical issue and expects repairs within three ...
Vertex Pharmaceuticals reported Phase 2b AMPLIFIED results for inaxaplin in APOL1-mediated kidney disease patients.
Ionis Pharmaceuticals reported positive Phase 3 results for ulefnersen in FUS-ALS, showing significant improvement versus ...
Ligand agreed to acquire royalty and milestone rights for Santen’s Ryjunea eye drop for $23 million upfront, expanding its ...
MillerKnoll reported lower Q1 fiscal 2027 sales but improved margins, higher adjusted EPS, stronger cash flow and continued ...
Lexeo Therapeutics agreed to acquire Mantle Therapeutics for up to $21.3 million, adding four Friedreich ataxia programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results